ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Proceedings Initiated Against Two Physicians At Dana-Farber

April 7, 1995

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Cancer Meetings Listed For May and June

April 23, 1993

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978

Greenberg Named UT System Vice Chancellor For Health Affairs

July 19, 2013